Development of ICP-OES Method for Determination Copper Tetramibi Tetrafluoroborate Active Substance Content in a Kit for Radiopharmaceutical Preparation.

The aim of this study was to develop a fast, quantitative method for the determination of copper tetramibi tetrafluoroborate active substance content in the POLATOM’s PoltechMIBI kit before radiolabeling, using inductively coupled plasma optical emission spectrometry (ICP-OES). Copper tetramibi is a key complex that after radiolabeling with sodium pertechnetate [99mTc], forms technetium [99mTc] sestamibi used primarily for detection of myocardial perfusion abnormalities. Indirect method that determines Cu content was developed and validated according to ICH guidelines and European Pharmacopoeia validation requirements, showing good linearity, accuracy, precision and intermediate precision between two different ICP-OES systems, making it suitable and adequate for routine analysis.

Authors

Institutions

Publication Details

Journal
Acta Poloniae Pharmaceutica - Drug Research
Published
2025-04-09
DOI
https://doi.org/10.32383/appdr/201435
Primary Topic
Analytical chemistry methods development
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of ICP-OES Method for Determination Copper Tetramibi Tetrafluoroborate Active Substance Content in a Kit for Radiopharmaceutical Preparation.

Magdalena Fiszer, Łukasz Sochaczewski, Anna Filiks
Acta Poloniae Pharmaceutica - Drug Research
Analytical chemistry methods development
article

Development of ICP-OES Method for Determination Copper Tetramibi Tetrafluoroborate Active Substance Content in a Kit for Radiopharmaceutical Preparation.

Magdalena Fiszer, Łukasz Sochaczewski, Anna Filiks
article en

Abstract

The aim of this study was to develop a fast, quantitative method for the determination of copper tetramibi tetrafluoroborate active substance content in the POLATOM’s PoltechMIBI kit before radiolabeling, using inductively coupled plasma optical emission spectrometry (ICP-OES). Copper tetramibi is a key complex that after radiolabeling with sodium pertechnetate [99mTc], forms technetium [99mTc] sestamibi used primarily for detection of myocardial perfusion abnormalities. Indirect method that determines Cu content was developed and validated according to ICH guidelines and European Pharmacopoeia validation requirements, showing good linearity, accuracy, precision and intermediate precision between two different ICP-OES systems, making it suitable and adequate for routine analysis.

Acta Poloniae Pharmaceutica - Drug ResearchVol. 81(6)
National Centre for Nuclear Research (PL)
Openalex Percentile: Top 92%
Analytical chemistry methods development
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of ICP-OES Method for Determination Copper Tetramibi Tetrafluoroborate Active Substance Content in a Kit for Radiopharmaceutical Preparation. — Magdalena Fiszer, Łukasz Sochaczewski, et al. · Acta Poloniae Pharmaceutica - Drug Research (2025) | TGRS Research Map | TGRS